You can buy or sell Precigen and other stocks, options, ETFs, and crypto commission-free!
Precigen, Inc. Common Stock, also called Precigen, is a biotechnology company, which engages in the research and development of synthetic biology technologies. Read More The firm focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. It operates through the following segments: PGEN Therapeutics, ActoBio, MBP Titan, Trans Ova and All Other. The PGEN Therapeutics segment is advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders and infectious diseases. The ActoBio segment involves in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The MBP Titan segment comprises of Methane Bioconversion Platform, and associated technologies, personnel, and facilities The Trans Ova segment includes provides advanced reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD. The listed name for PGEN is Precigen, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 10, Pre-Market